BC

Boxer Capital Portfolio holdings

AUM $2.04B
1-Year Return 108.35%
This Quarter Return
-20.17%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.95B
AUM Growth
-$568M
Cap. Flow
+$92.5M
Cap. Flow %
4.76%
Top 10 Hldgs %
47.94%
Holding
79
New
8
Increased
5
Reduced
2
Closed
4

Top Buys

1
APLS icon
Apellis Pharmaceuticals
APLS
+$66.2M
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$64.7M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$40.6M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$28.3M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$26.1M

Top Sells

1
XBI icon
SPDR S&P Biotech ETF
XBI
+$135M
2
ITOS
iTeos Therapeutics
ITOS
+$37.1M
3
RACB
Research Alliance Corp. II Class A Common Stock
RACB
+$4.89M
4
JYAC
Jiya Acquisition Corp. Class A Common Stock
JYAC
+$4.89M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$3.96M

Sector Composition

1 Healthcare 96.15%
2 Financials 0.61%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$164M 8.45%
2,000,000
– –
SWTX
2
DELISTED
SpringWorks Therapeutics
SWTX
$117M 6.02%
2,075,905
– –
ITOS
3
DELISTED
iTeos Therapeutics
ITOS
$103M 5.28%
3,192,058
-1,152,958
-27% -$37.1M
ONC
4
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.7B
$94.3M 4.85%
500,000
– –
RVMD icon
5
Revolution Medicines
RVMD
$8.7B
$88.9M 4.57%
3,484,264
– –
RLAY icon
6
Relay Therapeutics
RLAY
$688M
$79.9M 4.11%
2,669,132
– –
CYTK icon
7
Cytokinetics
CYTK
$6.12B
$77.3M 3.97%
2,100,000
– –
PMVP icon
8
PMV Pharmaceuticals
PMVP
$65.2M
$72.8M 3.74%
3,498,636
+660,400
+23% +$13.7M
TYRA icon
9
Tyra Biosciences
TYRA
$667M
$69M 3.55%
6,448,359
– –
APLS icon
10
Apellis Pharmaceuticals
APLS
$3.14B
$66.2M 3.4%
+1,303,700
New +$66.2M
RXDX
11
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$64.7M 3.33%
+1,714,000
New +$64.7M
XBI icon
12
SPDR S&P Biotech ETF
XBI
$5.43B
$62.9M 3.23%
700,000
-1,500,000
-68% -$135M
TNGX icon
13
Tango Therapeutics
TNGX
$727M
$52.1M 2.68%
6,871,642
– –
MRUS icon
14
Merus
MRUS
$5.26B
$50.2M 2.58%
1,900,000
– –
RCUS icon
15
Arcus Biosciences
RCUS
$1.23B
$45.2M 2.32%
1,432,200
– –
RETA
16
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$40.6M 2.09%
+1,239,000
New +$40.6M
SAGE
17
DELISTED
Sage Therapeutics
SAGE
$36.2M 1.86%
1,094,000
– –
BPMC
18
DELISTED
Blueprint Medicines
BPMC
$32.4M 1.67%
507,374
– –
IOVA icon
19
Iovance Biotherapeutics
IOVA
$821M
$32.2M 1.66%
1,935,133
+835,133
+76% +$13.9M
ANAB icon
20
AnaptysBio
ANAB
$655M
$32.2M 1.65%
1,300,000
– –
ACAD icon
21
Acadia Pharmaceuticals
ACAD
$3.98B
$30.6M 1.57%
1,263,930
+1,078,930
+583% +$26.1M
AMLX icon
22
Amylyx Pharmaceuticals
AMLX
$1.24B
$28.3M 1.45%
+2,200,000
New +$28.3M
IDYA icon
23
IDEAYA Biosciences
IDYA
$2.16B
$24.6M 1.27%
2,202,812
– –
RCKT icon
24
Rocket Pharmaceuticals
RCKT
$341M
$23.3M 1.2%
1,466,051
– –
NUVB icon
25
Nuvation Bio
NUVB
$1.07B
$22.8M 1.17%
4,341,009
– –
1
2 3 4